Page last updated: 2024-08-24

benidipine and Diabetic Angiopathies

benidipine has been researched along with Diabetic Angiopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, S; Hattori, Y; Jesmin, S; Kitabatake, A; Sakuma, I	1

Other Studies

1 other study(ies) available for benidipine and Diabetic Angiopathies

Article	Year
Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model. Diabetologia, 2002, Volume: 45, Issue:3 Topics: Animals; Calcium Channel Blockers; Capillaries; Collagen; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dihydropyridines; Disease Models, Animal; Endothelial Growth Factors; Fibroblast Growth Factor 2; Gene Expression Regulation; Lymphokines; Male; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Strains; RNA, Messenger; Species Specificity; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002

Article

Year

Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.

Diabetologia, 2002, Volume: 45, Issue:3

Topics: Animals; Calcium Channel Blockers; Capillaries; Collagen; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dihydropyridines; Disease Models, Animal; Endothelial Growth Factors; Fibroblast Growth Factor 2; Gene Expression Regulation; Lymphokines; Male; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Strains; RNA, Messenger; Species Specificity; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002